ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer

Abstract We have identified endoplasmic reticulum oxidoreductase 1 alpha (ERO1A) as a poor prognostic indicator in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (EGFR MUT-NSCLC). In addition, comparison of high versus low ERO1A expression among cohorts of EGFR MUT-NSCLC...

Full description

Saved in:
Bibliographic Details
Main Authors: M. A. Voronkova, B. Johnson, N. Gandhi, J. M. Koomen, M Patrick, S. Shanthi Bhupathi, V. M. Wu, A. Elliott, A. Vanderwalde, B. Halmos, L. A. Hazlehurst
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-024-00736-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items